UPDATE 1-Novartis says US approves Tasigna cancer drug - Reuters


Dog Flu Diet and Diseases
UPDATE 1-Novartis says US approves Tasigna cancer drug
Reuters -Oct 29, 2007
ZURICH, Oct 29 (Reuters) - US regulators have approved Novartis AG's (NOVN.VX: Quote, Profile, Research) Tasigna drug for use in chronic myeloid leukemia (CML) for patients who no longer respond to Glivec, the Swiss company said on Monday.
FDA OKs Novartis Cancer DrugTheStreet.com
Tasigna Approved for Chronic Myeloid LeukemiaU.S. News & World Report
Wired News - MedHeadlines - AHN - FDA.gov
all 132 news articles

More: continued here

Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
  • BlinkList
  • blogmarks
  • co.mments
  • del.icio.us
  • De.lirio.us
  • digg
  • Furl
  • Ma.gnolia
  • NewsVine
  • Reddit
  • Shadows
  • Simpy
  • Smarking
  • Spurl
  • YahooMyWeb



   Posted in Health News    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.





No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment